FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2012/12/003187 [Registered on: 06/12/2012] Trial Registered Retrospectively
Last Modified On: 29/09/2013
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Other (Specify) [Pain relief]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of ropivacaine (a local anaesthetic) and ropivacaine with fentanyl (an analgesic) injected adjacent to thoracic vertebra to provide pain relief in patients with multiple rib fractures  
Scientific Title of Study   Continuous paravertebral infusion of ropivacaine with or without fentanyl for pain relief in unilateral multiple fractured ribs - a prospective randomized double blind evaluation 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
2010/2832  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Medha Mohta 
Designation  Associate Professor 
Affiliation  University College of Medical Sciences and Guru Teg Bahadur Hospital 
Address  Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital

East
DELHI
110095
India 
Phone  9868399626  
Fax    
Email  medhamohta@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr L Emeni Ophrii 
Designation  DNB student 
Affiliation  University College of Medical Sciences and Guru Teg Bahadur Hospital 
Address  Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital

East
DELHI
110095
India 
Phone    
Fax    
Email  eophrii@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Medha Mohta 
Designation  Associate Professor 
Affiliation  University College of Medical Sciences and Guru Teg Bahadur Hospital 
Address  Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital

East
DELHI
110095
India 
Phone  9868399626  
Fax    
Email  medhamohta@hotmail.com  
 
Source of Monetary or Material Support  
University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi 110095 
 
Primary Sponsor  
Name  University College of Medical Sciences and Guru Teg Bahadur Hospital 
Address  University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi 110095 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr AK Sethi  Director Professor and Head, Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi 110095 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Medha Mohta  Department of Anaesthesiology and Critical Care, UCMS and GTB Hospital  Department of Anaesthesiology and Critical Care, 2nd Floor, OT Block, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden
East
DELHI 
9868399626

medhamohta@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Academic and Ethical Committee, Guru Teg Bahadur Hospital, Govt of NCT of Delhi   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Unilateral multiple rib fractures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Paravertebral ropivacaine  A bolus dose of ropivacaine 0.5% 0.3ml/kg followed by continuous infusion of ropivacaine 0.375% + adrenaline 5 µg/ml at a rate of 0.1-0.2 ml/kg/hr through paravertebral catheter until achievement of complete pain relief 
Intervention  Paravertebral ropivacaine with fentanyl  A bolus dose of ropivacaine 0.5% 0.3 ml/kg bolus followed by continuous infusion of ropivacaine 0.2% + adrenaline 5 µg/ml + fentanyl 2 µg/ml at a rate of 0.1-0.2 ml/kg/hr through paravertebral catheter until achievement of complete pain relief 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients having three or more unilateral fractured ribs 
 
ExclusionCriteria 
Details  • Unconscious patients
• Patients with unstable cardiac status or severely altered mental status
• Known liver/kidney disease
• Known allergy to local anaesthetic drugs
• Infection at site of needle insertion
• Pre-existing spinal deformity
• Patients having significant trauma outside chest wall, e.g. acute spine or pelvic fracture, severe traumatic brain or spinal cord injury or abdominal visceral injuries

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Rescue analgesic (morphine) requirement  Throughout study period till VAS score at rest and on coughing was not more than 10 to 15 mm for more than 8 hours 
 
Secondary Outcome  
Outcome  TimePoints 
• VAS pain scores at rest and on coughing
• Respiratory rate
• Peak expiratory flow rate
• Arterial oxygen saturation (SpO2)
• PaO2/FiO2 ratio
 
Before administration of block, 30 min after block, every 6 hours on 1st day and then every 8 hours 2nd day onwards  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   18/03/2010 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This was a prospective, randomized, double blind, parallel group trial to evaluate and compare the analgesic effect of continuous infusions of either ropivacaine 0.375% with adrenaline 5 µg/ml or a combination of fentanyl 2 µg/ml and ropivacaine 0.2% with adrenaline 5 µg/ml in patients with unilateral multiple rib fractures. Drug related side effects, if any, and the outcome in terms of length of ICU and hospital stay and pulmonary complications in the two groups were also compared.

 

 
Close